33 completed, 7 unknown, 4 recruiting, 2 terminated. 48 Phase 2, 6 Phase 1, 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 48 | Completed 33, Unknown 7, Recruiting 4, Terminated 2, Suspended 1, Withdrawn 1 |
| Phase 1 | 6 | Completed 5, Unknown 1 |
| Phase 3 | 6 | Completed 4, Suspended 1, Unknown 1 |
Follow Behavior Therapy: new trials by email Literature Review of Behavior Therapy trials Research Report on Behavior Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial IL-22, Prednisone, Acamprosate - Alcohol-associated Hepatitis | Phase 2 | Recruiting | Samer Gawrieh | 216 | 2026-01-27 | 2026-07-15 |
| Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial Antiandrogen Therapy, Behavioral Intervention, Biospecimen Collection - Prostate Carcinoma, Recurrent Prostate Carcinoma | Phase 2 | Recruiting | City of Hope Medical Center | 60 | 2025-11-05 | 2026-08-17 |
| Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors StrokeWear Motor and Behavioral Intervention, Usual Care - Stroke, Stroke Sequelae | Phase 2 | Recruiting | Spaulding Rehabilitation Hospital | 32 | 2025-03-20 | 2025-11-28 |
| Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD Behavior therapy, Psychoeducation - Autism Spectrum Disorder | Phase 2 / Phase 3 | Unknown | Stanford University | 90 | 2024-01-05 | 2024-08-27 |
| A Study of Cytisinicline for Vaping Cessation in Adult Smokers cytisinicline, Placebo, Behavioral support - Vaping, E-Cig Use | Phase 2 | Completed | Achieve Life Sciences | 160 | 2022-07-13 | 2026-01-14 |
| Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder Cannabidiol (CBD) oral solution, Placebo, Massed Prolonged Exposure (mPE) - Posttraumatic Stress Disorder, Stress Disorders, Post-Traumatic | Phase 1 / Phase 2 | Completed | The University of Texas Health Science Center at San Antonio | 21 | 2022-04-04 | 2024-10-10 |
| High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma High dose Gemcitabine, Busulfan, and Thiotepa as conditioning therapy - Primary Central Nervous System Lymphoma (PCNSL) | Phase 2 | Recruiting | Sichuan University | 34 | 2022-01-01 | 2025-06-11 |
| Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors One Diet and Physical Activity Session, Electronic (e) Health (eHealth) Communication Intervention, Twelve Diet and Physical Activity Group Sessions - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Completed | Fred Hutchinson Cancer Center | 90 | 2020-02-21 | 2021-11-04 |
| Guanfacine to Improve Substance Use Outcomes in Women Guanfacine, Behavioral Counseling - Substance Use Disorders | Phase 2 | Completed | Yale University | 74 | 2019-11-01 | 2024-03-20 |
| Trial of Cytisine in Adult Smokers Cytisine, Placebo Comparator, Behavioral support - Smoking Cessation | Phase 2 | Completed | Achieve Life Sciences | 254 | 2018-11-13 | 2020-05-18 |
| Prostate Cancer Survivors and Exercise and Behavioral Counseling Supervised Physical Activity Plus Behavioral Counseling, Supervised Physical Activity Plus Exercise Counseling - Physical Activity, Cancer of the Prostate | Phase 2 | Completed | University of Illinois at Urbana-Champaign | 27 | 2017-07-06 | 2019-12-20 |
| The Efficacy of a VR Enhanced Video Exposure Therapy for Dental Phobia Behavior Therapy, Health Education - Dental Phobia | Phase 2 | Unknown | Ruhr University of Bochum | 100 | 2017-04-01 | 2017-03-31 |
| Different Neural Circuit Mechanisms Between Cognitive Therapy and Behavior Therapy for Patients With Panic Disorder: a Dynamic Research Cognitive therapy, Behavior therapy, SSRI antidepressants - Panic Disorder | Phase 2 | Unknown | Nanjing Medical University | 96 | 2016-01-01 | 2017-06-27 |
| Pre to Postoperative Smoking Cessation Varenicline, Contingency Management, Behavioral Counseling - Cigarette Smoking, Obesity | Phase 2 | Terminated | Johns Hopkins University | 5 | 2015-10-01 | 2018-07-17 |
| Very Low-Nicotine Cigarettes in Smokers With SUD Nicotine, behavioral counseling for smoking cessation - Nicotine Dependence | Phase 2 | Completed | Brown University | 250 | 2014-04-01 | 2021-09-28 |
| D-cycloserine and Treatment of Feeding Disorders Behavioral Intervention, d-cycloserine (DCS), Placebo - Feeding Disorders, Specific Phobia | Phase 1 / Phase 2 | Completed | Emory University | 16 | 2013-03-01 | 2014-10-23 |
| VoIP Delivered Behavior Therapy for Tourette Syndrome Behavior Therapy for Tics (CBIT) - Tourette Syndrome, Chronic Tic Disorder | Phase 2 | Completed | University of Wisconsin, Milwaukee | 20 | 2012-12-01 | 2014-09-23 |
| Combination Treatment for Augmenting Language in Children With ASD Behavioral Therapy, Aripiprazole, Placebo - Autism Spectrum Disorder | Phase 2 | Completed | University of California, Los Angeles | 58 | 2012-06-01 | 2020-04-29 |
| A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence EVP-6124, Placebo Capsule, NicoDerm Patch (Active) - Nicotine Dependence, Smoking Cessation | Phase 2 | Terminated | A. Eden Evins | 345 | 2011-12-01 | 2017-04-06 |
| Efficacy of Varenicline for Smokeless Tobacco Use in India Varenicline, Counseling - Tobacco Use Disorder | Phase 2 | Completed | University of Pennsylvania | 237 | 2011-04-01 | 2015-07-30 |
Showing 20 of 48. Sign in to see all of them.
Tobacco Use Disorder (9) · Smoking Cessation (5) · Depression (3) · Obesity (3) · Substance-Related Disorders (3) · Alcoholism (2) · Autism Spectrum Disorder (2) · Behavior, Addictive (2) · Cocaine-Related Disorders (2) · Motor Activity (2) · Panic Disorder (2) · Prostatic Neoplasms (2) · Weight Loss (2) · Acquired Immunodeficiency Syndrome (1) · Acute Disease (1)
National Institute on Drug Abuse (NIDA) (7) · Yale University (4) · Achieve Life Sciences (2) · University of California, Los Angeles (2) · University of Wisconsin, Milwaukee (2) · A. Eden Evins (1) · Brown University (1) · City of Hope Medical Center (1) · Emory University (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Fred Hutchinson Cancer Center (1) · Johns Hopkins University (1) · Kaiser Permanente (1) · Nanjing Medical University (1) · National Development and Research Institutes, Inc. (1)
United States (44) · China (2) · India (1)
Dorothy Hatsukami, PhD (2) · Adam G Tsai, MD, MSCE (1) · Anne Eden Evins, MD, MPH (1) · Anne Joseph, MD (1) · Art F Kramer, PhD (1) · Barbara Andersen, Ph.D. (1) · Barbara J. Mason, PhD (1) · Barbara Milrod, M.D. (1) · Carolyn L. Turvey, PhD (1) · Casey Straud, PsyD (1) · Chun Wang, doctor (1) · Cynthia J. Brown, MD MSPH (1) · Damaris J Rohsenow, PhD (1) · Daniel Cain, Vice-President Clinical Research (1) · Douglas W Woods, PhD (1)
PMID 17592913, PMID 19026262, PMID 19050988, PMID 20542391, PMID 24153411, PMID 24190578, PMID 25142566, PMID 25622198, PMID 25952160, PMID 26317176, PMID 26918564, PMID 27161025, PMID 27194309, PMID 27243899, PMID 27597745, PMID 27724833, PMID 29371234, PMID 29389510, PMID 29770461, PMID 30389377, PMID 30709403, PMID 30929703, PMID 32880104, PMID 32979134, PMID 35788100, PMID 36336249, PMID 37142273, PMID 38277162, PMID 38330639, PMID 38709500, PMID 38761558, PMID 42190642
F31MH096375 (1), K23AT003678 (1), K23MH001849 (1), K24DK065018 (1), KL2TR002646 (1), P30CA033572 (1), P50AA015632 (1), P50DA013333 (1), R01AA011197 (1), R01DA006915 (1), R01DA019989 (1), R01DA030992 (1), R01DA047094 (1), R01MH080966 (1), R21DA018075 (1)